Antiviral host defense through selective translational inhibition
通过选择性翻译抑制进行抗病毒宿主防御
基本信息
- 批准号:8892204
- 负责人:
- 金额:$ 29.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemATP phosphohydrolaseAffectAlternative SplicingAnti-Retroviral AgentsAntigensAntiviral AgentsAntiviral ResponseAreaAttenuatedBindingBiogenesisBiological ProcessCaenorhabditis elegansCellsChargeCodon NucleotidesCommunicable DiseasesDNADevelopmentDiagnosticDiseaseDominant-Negative MutationDrosophila genusERG geneEmployee StrikesEventFamilyGenerationsGenesGenetic TranscriptionGoalsHIVHIV InfectionsHomologous GeneHost DefenseHumanIRF3 geneImmune responseInfectionInfection preventionInfluenzaInterferon-alphaInterferonsKineticsLengthLightLocationMediatingMessenger RNAMolecularMolecular Mechanisms of ActionMulti-Drug ResistanceMusN-terminalNucleic Acid BindingOrganismPathway interactionsPharmaceutical PreparationsPositioning AttributePoxviridaeProcessProductionProtein BindingProtein BiosynthesisProtein InhibitionProtein IsoformsProtein Synthesis InhibitionProteinsRNA HelicaseReportingRetroviridaeReverse TranscriptionRoleShapesSpecificityStagingSystemTestingTherapeuticTherapeutic InterventionTransfer RNATranslational RepressionViralViral ProteinsVirusYeastsbasemembermicrobialnovelpathogenpreferenceprognostic valueprospectiveprotein expressionprotein functiontoolviral RNA
项目摘要
DESCRIPTION (provided by applicant): HIV continues to be one of the most prevalent infectious diseases in this world. Our discovery of a novel cellular factor that inhibits the production of HIV by infected cells provides a new target for the development of a novel class of anti-viral drugs and may additionally carry diagnostic and prognostic value. Furthermore, based on the molecular basis of the antiviral activity we hypothesize that other viruses such as Influenza will also be subject to inhibition by huSlfn11.
描述(由申请人提供):艾滋病毒仍然是世界上最流行的传染病之一。我们发现了一种新的细胞因子,可以抑制感染细胞产生HIV,这为开发新型抗病毒药物提供了新的靶点,并可能具有诊断和预后价值。此外,基于抗病毒活性的分子基础,我们假设其他病毒如流感病毒也会受到huSlfn11的抑制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL DAVID其他文献
MICHAEL DAVID的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL DAVID', 18)}}的其他基金
Translational inhibition by Schlafen proteins during the DNA damage response
DNA 损伤反应期间 Schlafen 蛋白的翻译抑制
- 批准号:
10080748 - 财政年份:2019
- 资助金额:
$ 29.45万 - 项目类别:
The IRF-type I interferon system during gestation
妊娠期间的 IRF-I 型干扰素系统
- 批准号:
9300592 - 财政年份:2017
- 资助金额:
$ 29.45万 - 项目类别:
DNA structure modification by the Schlafen protein family
Schlafen 蛋白家族对 DNA 结构的修饰
- 批准号:
9238658 - 财政年份:2016
- 资助金额:
$ 29.45万 - 项目类别:
The IRF - type I interferon system in T cell-mediated immune tolerance
IRF-I型干扰素系统在T细胞介导的免疫耐受中的作用
- 批准号:
8492601 - 财政年份:2013
- 资助金额:
$ 29.45万 - 项目类别:
The IRF - type I interferon system in T cell-mediated immune tolerance
IRF-I型干扰素系统在T细胞介导的免疫耐受中的作用
- 批准号:
8607894 - 财政年份:2013
- 资助金额:
$ 29.45万 - 项目类别:
Antiviral host defense through selective translational inhibition
通过选择性翻译抑制进行抗病毒宿主防御
- 批准号:
8473888 - 财政年份:2012
- 资助金额:
$ 29.45万 - 项目类别:
Antiviral host defense through selective translational inhibition
通过选择性翻译抑制进行抗病毒宿主防御
- 批准号:
8660064 - 财政年份:2012
- 资助金额:
$ 29.45万 - 项目类别:
Antiviral host defense through selective translational inhibition
通过选择性翻译抑制进行抗病毒宿主防御
- 批准号:
8914843 - 财政年份:2012
- 资助金额:
$ 29.45万 - 项目类别: